about
Endothelin is an important determinant of renal function in a rat model of acute liver and renal failureEffect of PGE1 on TNF-alpha status and hepatic D-galactosamine-induced apoptosis in ratsAlterations in the mouse and human proteome caused by Huntington's disease.Regulation of innate responses during pre-patent schistosome infection provides an immune environment permissive for parasite development.Expression of hepatic thrombopoietin mRNA in primary cultured hepatocytes and in rats with acute liver injury or bone marrow suppression with or without cirrhosis.Endogenous leukemia inhibitory factor attenuates endotoxin response.The major acute-phase protein, serum amyloid P component, in mice is not involved in endogenous resistance against tumor necrosis factor alpha-induced lethal hepatitis, shock, and skin necrosis.Inhibition of 5-lipoxygenase pathway attenuates acute liver failure by inhibiting macrophage activationAnimal models of acute hepatic failure.Galactosamine-induced sensitization to the lethal effects of endotoxin.Galactosamine induced hepatitis induces a reduction in hepatocyte epidermal growth factor receptorsBehaviour of 125I-fibrinogen and 131I-albumin in experimental galactosamine-induced hepatitis.The biochemical pathology of liver cell necrosis.Non-invasive detection of drug toxicity in rats by solid-phase extraction and MALDI-TOF analysis of urine samples.Transcriptome of extracellular vesicles released by hepatocytes.Human leukocyte antigen class II transgenic mouse model unmasks the significant extrahepatic pathology in toxic shock syndromeIdentification of noninvasive biomarkers for nephrotoxicity using HK-2 human kidney epithelial cells.TNF-alpha dependent production of inducible nitric oxide is involved in PGE(1) protection against acute liver injury.Therapies from fucoidan; multifunctional marine polymers.Adipose-derived stem cell-based treatment for acute liver failureTumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.Galactosamine-induced cell death in primary cultures of rat hepatocytes.Prevention of galactosamine-induced liver cell necrosis by uridine.Early, reversible plasma membrane injury in galactosamine-induced liver cell death.Health-promoting effects of green teaAnti-hepatitis B virus effect and possible mechanism of action of 3,4-o-dicaffeoylquinic Acid in vitro and in vivoProtective Properties of Laggera alata Extract and its Principle Components Against d-Galactosamine-Injured Hepatocytes.Experimental galactosamine-induced hepatitis. Effect of anticoagulant and antifibrinolytic agents on microclot formation.T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6.Serum UPLC-MS/MS metabolic profiling in an experimental model for acute-liver injury reveals potential biomarkers for hepatotoxicity.A model of decreased functional alpha-1-proteinase inhibitor. Pulmonary pathology of dogs exposed to chloramine T.The p53 Codon 72 Polymorphism Modifies the Cellular Response to Inflammatory Challenge in the LiverImpact of asialoglycoprotein receptor deficiency on the development of liver injury.Green tea extract supplement reduces D-galactosamine-induced acute liver injury by inhibition of apoptotic and proinflammatory signaling.An overview of animal models for investigating the pathogenesis and therapeutic strategies in acute hepatic failure.Quantitative proteomic analysis of hepatocyte-secreted extracellular vesicles reveals candidate markers for liver toxicityCell Therapy for Acute Liver Failure - Ideal source of cell.Mechanisms of cell death in acute liver failure.Fulminant liver failure model with hepatic encephalopathy in the mouse.Ideal Experimental Rat Models for Liver Diseases
P2860
Q28344364-53EC5A33-08CF-41C8-AD1C-1E0D7B69A765Q28374442-B17C2779-7268-4D1F-B6BA-E9694A1C6DBFQ31096639-2DB9A335-49DD-4A9A-9C28-853970AE27EAQ31141885-535DC5AC-D3A1-49F4-9FB1-E086FD93E6F1Q33333370-B590DAAB-392D-48B0-9995-FCBF948EAC14Q33364906-53315963-6135-4085-B688-15C1A840A2A3Q33598362-26E50ED5-E814-45BE-9FB1-1B9CA3E8706DQ33759028-DAF2EF4F-E76F-4C2C-A810-E23C7699B90EQ33890380-391BE217-20D4-4B6B-BD40-2208DD56F2C9Q33983065-34143BEA-E5C3-4484-BAFF-7AE6F8DFFEFBQ34395780-75B7ACBF-06ED-4D2D-92BA-82779A4E0DE4Q34473187-12A770E2-9F84-4800-896F-13B00C2BF890Q34502146-6FEF3FCA-0C18-46FA-9175-0976419D322AQ34546734-BAE4D597-E9C1-4A9B-B70C-F47B0F034A86Q34850542-0477D9B4-45E1-40A7-A676-F3F0509C325DQ35071467-016ADCF1-2BF7-4F90-9E94-F6A97E7A9C7BQ35198566-B0541ABC-890A-4216-9C74-BC03BFC6C31BQ35361740-9732721D-C481-4ACC-ADEE-15F47BDE82B6Q35534899-1E17CC80-D416-476C-B943-F66AE24F23C2Q35588254-536FC0BD-A606-41AB-8908-E6833EE64A72Q35795137-39CD6009-7578-4BBB-9724-F86EFBA89388Q35863980-8ADB5C14-D9BC-4610-9C83-4F7A6D98068DQ35864456-E832B7C1-2A41-48DE-B65F-0F684B1AB045Q35877980-0C9F499E-924E-4296-9D6D-F79533DBD0C7Q36001534-E221DA7F-CC19-4FBC-9846-F7B5FB58BD90Q36022073-5E7FBF6D-9D53-4D21-BA08-546F3DBE5F8BQ36058595-8E605FDC-46A3-4110-A6DD-53EB0631FCBBQ36077826-08643084-7B21-4827-AD01-D367750E574CQ36363056-2A371CEB-1400-4C17-8A20-3A00C0A85785Q36375764-BB1988FA-E2D1-4B87-8A1C-D76C2B4541D1Q37004773-EAB0D370-CFAC-4789-B22B-96DF52523FA0Q37120247-4494A1DD-646C-460C-8AF9-FBC568CF86C1Q37135962-64DB96CB-9EDC-4C8D-9B52-CBFF01FE6370Q37154069-617F04CC-92CD-4293-936F-508CCA96F97CQ37250336-EAA8B012-7E7F-41ED-8B30-97D820AEE4CEQ37428949-1A7AF598-D16F-41A4-A98E-DCCDF189A959Q37536073-CF0D3809-5A41-4257-A094-C9523D0E5A16Q38000987-696EB2BA-8259-458C-9668-73DE72BC53DCQ38354469-A80F0ADA-B92F-4C9B-89CF-87D25FD29397Q38595585-2C9EAE56-3C12-418A-AFAB-EC7D1EF7CB87
P2860
description
1968 nî lūn-bûn
@nan
1968年の論文
@ja
1968年学术文章
@wuu
1968年学术文章
@zh
1968年学术文章
@zh-cn
1968年学术文章
@zh-hans
1968年学术文章
@zh-my
1968年学术文章
@zh-sg
1968年學術文章
@yue
1968年學術文章
@zh-hant
name
Experimental hepatitis induced by D-galactosamine.
@en
Experimental hepatitis induced by D-galactosamine.
@nl
type
label
Experimental hepatitis induced by D-galactosamine.
@en
Experimental hepatitis induced by D-galactosamine.
@nl
prefLabel
Experimental hepatitis induced by D-galactosamine.
@en
Experimental hepatitis induced by D-galactosamine.
@nl
P2093
P1476
Experimental hepatitis induced by D-galactosamine.
@en
P2093
P304
P356
10.1016/0014-4800(68)90042-7
P577
1968-10-01T00:00:00Z